The relationship between influenza vaccination and outpatient visits for upper respiratory infection by the elderly in Taiwan

Value in Health

Volumn 10, Issue 2, 2007, Pages 117-127

  Tsai, Yi Wen ^a,b   Huang, Weng Foung ^a,c   Wen, Yu Wen ^b   Chen, Pei Fen ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Influenza vaccine; Survival analysis; Taiwan; Upper respiratory infection

Indexed keywords

AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; INFLUENZA VACCINATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; SCORING SYSTEM; SEASONAL VARIATION; SURVIVAL; TAIWAN; UPPER RESPIRATORY TRACT INFECTION;

EID: 33947584598     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2006.00158.x     Document Type: Article

References (47)

1. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
2. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med 1998;158:645-50.
3. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76.
4. Ambrosch F, Fedson DS. Influenza vaccination in 29 countries: an update to 1997. Pharmacoeconomics 1999;16(Suppl. 1):S47-54.
5. Demicheli V. Mass influenza vaccination in Ontario: is it worthwhile? CMAJ 2001;164:38-9.
6. Yoo BK, Frick K. Determinants of influenza vaccination timing. Health Econ 2005;14:777-91.
7. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995;123:518-27.
8. Govaert TM, Thijs CT, Masurel N, et al. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994;272:1661-5.
9. Foster D, Talsma A, Furumoto-Dawson A, et al. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly. Am J Epidemiol 1992;136:296-307.
10. Mullooly JP, Bennett MD, Hornbrook MC, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994;121:947-52.
11. Nichol KL, Goodman M. The health and economic benefits of influenza vaccination for healthy and atrisk persons aged 65-74 years. Pharmacoeconomics 1999;16(Suppl. 1):63-71.
12. Christenson B, Lundbergh P, Hedlund J, et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001;357:1008-11.
13. Ohmit S, Monto A. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons. Int J Epidemiol 1995;24:1240-8.
14. Ahmed AH, Nicholson KG, Nguyen-van Tam JS, et al. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect 1997;118:27-33.
15. Ahmed AEH, Nicholson KG. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 1995;346:591-5.
16. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
17. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403.
18. Voordouw BCG, van der Linden PD, Simonian S, et al. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med 2003;163:1089-94.
19. Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999;17(Suppl. 1):S47-52.
20. Berg GD, Thomas E, Silverstein S, et al. Reducing medical service utilization by encouraging vaccines: randomized controlled trial. Am J Prev Med 2004;27:284-8.
21. Nichol KL, Goodman M. Cost effectiveness of influenza vaccination for healthy persons between ages 65 and 74 years. Vaccine 2002;20(Suppl. 2):S21-4.
22. Helliwell BE, Drummond MF. The costs and benefits of preventing influenza in Ontario elderly. Can J Public Health 1988;79:175-80.
23. Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002;20:2562-78.
24. Postma MJ, Bos JM, van Gennep M, et al. Economic evaluation of influenza vaccination: assessment for The Netherlands. Phamacoeconomics 1999;16(Suppl. 1):S33-40.
25. Scott WG, Scott HM. Economic evaluation of vaccination against influenza in New Zealand. Pharmacoeconomics 1996;9:51-60.
26. Wang C-S, Wang S-T, Chou P. Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community. Vaccine 2002;20:2494-9.
27. Fitzner KA, Shortridge KF, McGhee SM, et al. Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 2001;56:215-34.
28. Allsup S, Haycox A, Regan M, et al. Is influenza vaccination cost effective for healthy people between ages 65 and 74 years? A randomised controlled trial. Vaccine 2004;23:639-45.
29. Hak E, Verheij TJM, Grobbee DE, et al. Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications. J Epidemiol Community Health 2002;56:951-5.
30. Mullahy J. It'll only hurt a second? Microeconomic determinants of who gets flu shots. Health Econ 1999;8:9-24.
31. Ahituv A, Hotz VJ, Philipson T. The responsiveness of the demand for condoms to the local prevalence of AIDS. J Hum Resour 1996;31:869-97.
32. Philipson T. Private vaccination and public health: an empirical examination for U.S. measles. J Hum Resour 1996;31:611-30.
33. Wu S. Sickness and preventive medical behavior. J Health Econ 2003;22:675-89.
34. Nichol KL, Zimmerman R. Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: a nationwide survey. Arch Intern Med 2001;161:2702-8.
35. Wang S-T, Lee L-T, Chen L-S, et al. Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan. Vaccine 2005;23:1973-80.
36. Chen Y-H, Liou S-H, Chou C-C, et al. Influenza and pneumococcal vaccination of the elderly in Taiwan. Vaccine 2004;22:2806-11.
37. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
38. Centers of Disease Control and Prevention. Update: influenza activity - United States and worldwide, 2001-02 season, and composition of the 2002-03 influenza vaccine. MMWR 2002;51:503-6.
39. Center for Disease Control. Statistics of communicable diseases and surveillance report in Taiwan area, 2001. Taiwan: Center for Disease Control, 2003; 47-51.
40. Center for Disease Control. Statistics of communicable diseases and surveillance report in Taiwan area, 2002. Taiwan: Center for Disease Control, 2004; 50-3.
41. Chen Y-H, Liou S-H, Chou C-C, et al. Influenza and pneumococcal vaccination of the elderly in Taiwan. Vaccine 2004;22:2806-11.
42. Fedson DS, Hirota Y, Shin H-K, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997;15:1506-11.
43. Mark T, Paramore L. Pneumococcal pneumonia and influenza vaccination: access to and use by US Hispanic Medicare beneficiaries. Am J Public Health 1996;86:1545-50.
44. Honkanen PO, Keistinen T, Kivela S-L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997;15:317-20.
45. Zimmerman RK, Santibanez TA, Janosky JE, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices. Am J Med 2003;114:31-8.
46. van Essen GA, Kuyvenhoven MM, de Melker RA. Compliance with influenza vaccination: its relation with epidemiologic and sociopsychological factors. Arch Fam Med 1997;6:157-62.
47. Braitman LE, Rosenbaum PR. Rare outcomes, common treatments: analytic strategies using propensity score. Ann Intern Med 2002;137:693-5.